Please use this identifier to cite or link to this item:
|Title:||Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells||Authors:||Guglielmelli, Paola
Vannucchi, Alessandro M
|Keywords Plus:||HEMATOPOIETIC STEM-CELLS;MICRORNA-OFFSET RNAS;MYELOPROLIFERATIVE NEOPLASMS;POLYCYTHEMIA-VERA;ESSENTIAL THROMBOCYTHEMIA;MYELOID DEVELOPMENT;PROGENITOR CELLS;MESSENGER-RNA;BREAST-CANCER;IDENTIFICATION||Mesh headings:||Antigens, CD34;Lymphocytes;MicroRNAs;Primary Myelofibrosis||Secondary Mesh headings:||Adaptor Proteins, Signal Transducing;Base Sequence;Case-Control Studies;Gene Expression Regulation, Neoplastic;Granulocytes;Humans;Membrane Proteins;Molecular Sequence Data;Receptors, Fibroblast Growth Factor||Issue Date:||2015||Publisher:||PUBLIC LIBRARY SCIENCE||Journal:||PloS one||Abstract:||
Myeloproliferative neoplasms (MPN) are chronic myeloid cancers thought to arise at the level of CD34+ hematopoietic stem/progenitor cells. They include essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF). All can progress to acute leukemia, but PMF carries the worst prognosis. Increasing evidences indicate that deregulation of microRNAs (miRNAs) might plays an important role in hematologic malignancies, including MPN. To attain deeper knowledge of short RNAs (sRNAs) expression pattern in CD34+ cells and of their possible role in mediating post-transcriptional regulation in PMF, we sequenced with Illumina HiSeq2000 technology CD34+ cells from healthy subjects and PMF patients. We detected the expression of 784 known miRNAs, with a prevalence of miRNA up-regulation in PMF samples, and discovered 34 new miRNAs and 99 new miRNA-offset RNAs (moRNAs), in CD34+ cells. Thirty-seven small RNAs were differentially expressed in PMF patients compared with healthy subjects, according to microRNA sequencing data. Five miRNAs (miR-10b-5p, miR-19b-3p, miR-29a-3p, miR-379-5p, and miR-543) were deregulated also in PMF granulocytes. Moreover, 3'-moR-128-2 resulted consistently downregulated in PMF according to RNA-seq and qRT-PCR data both in CD34+ cells and granulocytes. Target predictions of these validated small RNAs de-regulated in PMF and functional enrichment analyses highlighted many interesting pathways involved in tumor development and progression, such as signaling by FGFR and DAP12 and Oncogene Induced Senescence. As a whole, data obtained in this study deepened the knowledge of miRNAs and moRNAs altered expression in PMF CD34+ cells and allowed to identify and validate a specific small RNA profile that distinguishes PMF granulocytes from those of normal subjects. We thus provided new information regarding the possible role of miRNAs and, specifically, of new moRNAs in this disease.
|Appears in Collections:||Articles|
Show full item record
checked on May 2, 2021
checked on Aug 31, 2020
WEB OF SCIENCETM
checked on Nov 26, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.